These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7370989

  • 1. Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.
    Von Hoff DD, Pollard E, Kuhn J, Murray E, Coltman CA.
    Cancer Res; 1980 May; 40(5):1516-8. PubMed ID: 7370989
    [Abstract] [Full Text] [Related]

  • 2. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).
    Von Hoff DD, Myers JW, Kuhn J, Sandbach JF, Pocelinko R, Clark G, Coltman CA.
    Cancer Res; 1981 Aug; 41(8):3118-21. PubMed ID: 6265075
    [Abstract] [Full Text] [Related]

  • 3. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS, Mackel C, Pocelinko R, Salmon SE.
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [Abstract] [Full Text] [Related]

  • 4. Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
    Legha SS, Gutterman JU, Hall SW, Benjamin RS, Burgess MA, Valdivieso M, Bodey GP.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3712-6. PubMed ID: 279397
    [Abstract] [Full Text] [Related]

  • 5. Phase I study of a 5-day schedule of mitoxantrone (dihydroxyanthracenedione).
    Wynert WR, Harvey HA, Lipton A, Schweitzer J, White DS.
    Cancer Treat Rep; 1982 Jun; 66(6):1303-6. PubMed ID: 7083234
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase I trial of dihydroxyanthracenedione.
    Van Echo DA, Whitacre MY, Aisner J, Wiernik PH.
    Cancer Treat Rep; 1981 Jun; 65(9-10):831-4. PubMed ID: 7273015
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II trial of 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino 9,10-anthracenedione dihydrochloride)(NSC 301739, DHAD) in patients with metastatic malignant melanoma. A Southwest Oncology Group pilot.
    Taylor SA, Tranum BT, Von Hoff DD, Costanzi JJ.
    Invest New Drugs; 1985 Jun; 3(1):67-9. PubMed ID: 3988458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of mitoxantrone in head and neck cancer.
    Aapro MS, Alberts DS.
    Invest New Drugs; 1984 Sep 15; 2(3):329-30. PubMed ID: 6511239
    [Abstract] [Full Text] [Related]

  • 17. Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione.
    Savaraj N, Lu K, Valdivieso M, Burgess M, Umsawasdi T, Benjamin RS, Loo TL.
    Clin Pharmacol Ther; 1982 Mar 15; 31(3):312-6. PubMed ID: 7060314
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct and indirect clastogenic activity of anthracenedione in Chinese hamster ovary cells.
    Rosenberg LJ, Hittelman WN.
    Cancer Res; 1983 Jul 15; 43(7):3270-5. PubMed ID: 6850635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.